05232019CM0345GLENVIEW – To help Illinoisans with diabetes afford life-saving medications, State Senator Laura Fine (D-Glenview) chief co-sponsored a new law that will cap the out-of-pocket cost of insulin at $100 for a 30-day supply starting Jan. 1, 2021 for patients on a state regulated insurance plan.

“For too long, people with diabetes have had to decide between purchasing food or life-saving medication,” said Senator Fine. “Especially when so many families are facing economic hardship, good health shouldn’t be a luxury—it’s a right.”

On Jan. 1, Illinois will become the second state in the nation to cap out-of-pocket insulin costs at $100 per month for all patients using a state regulated insurance plan, regardless of the supply they require.

Over 34 million Americans have diabetes, including 1.3 million Illinoisans, who rely on insulin to manage their blood sugar levels. Between 2009 and 2017, the price of insulin nearly tripled, leaving many patients struggling to pay for the drug and at risk of death without it.

The new law also requires the Departments of Insurance, Human Services, and Healthcare and Family Services to jointly issue an "insulin pricing report" to the public that details findings on insulin pricing practices and recommendations to control and prevent overpricing of prescription insulin drugs.

Senate Bill 667 passed the General Assembly with overwhelming bipartisan support in November 2019 and was signed into law in January 2020.

Category: Press Releases

COVID19 Resources

COVID19 Updates

Read Past e Newsletters

 

eNewsletter Signup
  1. First Name(*)
    Invalid Input
  2. Last Name(*)
    Invalid Input
  3. Email Address(*)
    Invalid Input

Contact Information

Springfield Office:
121C Capitol Building
Springfield, IL 62706
(217) 782-2119

District Office:
1812 Waukegan Road
Suite A
Glenview, IL 60025
(847) 998-1717

laura@senatorfine.com